NL2029775B1 - Method for detecting multiple advanced glycation end products in dairy products - Google Patents
Method for detecting multiple advanced glycation end products in dairy products Download PDFInfo
- Publication number
- NL2029775B1 NL2029775B1 NL2029775A NL2029775A NL2029775B1 NL 2029775 B1 NL2029775 B1 NL 2029775B1 NL 2029775 A NL2029775 A NL 2029775A NL 2029775 A NL2029775 A NL 2029775A NL 2029775 B1 NL2029775 B1 NL 2029775B1
- Authority
- NL
- Netherlands
- Prior art keywords
- standard curve
- dairy products
- standard
- method comprises
- concentration
- Prior art date
Links
- 108010005094 Advanced Glycation End Products Proteins 0.000 title claims abstract description 42
- 238000000034 method Methods 0.000 title claims abstract description 37
- 235000013365 dairy product Nutrition 0.000 title claims abstract description 27
- 150000002500 ions Chemical class 0.000 claims description 19
- RRUYWEMUWIRRNB-LURJTMIESA-N (2s)-6-amino-2-[carboxy(methyl)amino]hexanoic acid Chemical compound OC(=O)N(C)[C@H](C(O)=O)CCCCN RRUYWEMUWIRRNB-LURJTMIESA-N 0.000 claims description 18
- 238000001514 detection method Methods 0.000 claims description 17
- UENLDOJJKXLRJI-ZETCQYMHSA-N (2s)-6-amino-2-(2-carboxyethylamino)hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NCCC(O)=O UENLDOJJKXLRJI-ZETCQYMHSA-N 0.000 claims description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- VTYFITADLSVOAS-NSHDSACASA-N 1-(L-norleucin-6-yl)pyrraline Chemical compound OC(=O)[C@@H](N)CCCCN1C(CO)=CC=C1C=O VTYFITADLSVOAS-NSHDSACASA-N 0.000 claims description 10
- DCPBQSFZQHFSMR-QMMMGPOBSA-N argpyrimidine Chemical compound CC1=NC(NCCC[C@H](N)C(O)=O)=NC(C)=C1O DCPBQSFZQHFSMR-QMMMGPOBSA-N 0.000 claims description 10
- AYEKKSTZQYEZPU-RYUDHWBXSA-N pentosidine Chemical compound OC(=O)[C@@H](N)CCCCN1C=CC=C2N=C(NCCC[C@H](N)C(O)=O)N=C12 AYEKKSTZQYEZPU-RYUDHWBXSA-N 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 238000005903 acid hydrolysis reaction Methods 0.000 claims description 6
- 239000012279 sodium borohydride Substances 0.000 claims description 6
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 6
- NUXSIDPKKIEIMI-WCEGGVOZSA-N (2s)-2-amino-6-(carboxymethylamino)-4,4,5,5-tetradeuteriohexanoic acid Chemical compound OC(=O)CNCC([2H])([2H])C([2H])([2H])C[C@H](N)C(O)=O NUXSIDPKKIEIMI-WCEGGVOZSA-N 0.000 claims description 5
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000005238 degreasing Methods 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 4
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 claims description 4
- 235000019253 formic acid Nutrition 0.000 claims description 4
- -1 methyl acetaldehyde-hydroxyimidazolone Chemical compound 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000013467 fragmentation Methods 0.000 claims description 3
- 238000006062 fragmentation reaction Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000005173 quadrupole mass spectroscopy Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 238000004704 ultra performance liquid chromatography Methods 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 239000007853 buffer solution Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 229910000831 Steel Inorganic materials 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 239000010959 steel Substances 0.000 claims 1
- 239000011159 matrix material Substances 0.000 description 37
- 230000000694 effects Effects 0.000 description 24
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 13
- 235000013305 food Nutrition 0.000 description 10
- 235000013336 milk Nutrition 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- 239000012086 standard solution Substances 0.000 description 9
- 235000020191 long-life milk Nutrition 0.000 description 8
- 238000010828 elution Methods 0.000 description 6
- 239000012071 phase Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229910021642 ultra pure water Inorganic materials 0.000 description 4
- 239000012498 ultrapure water Substances 0.000 description 4
- 239000012491 analyte Substances 0.000 description 3
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- BOOXYSZJUWVNRE-JEDNCBNOSA-N (2s)-2,6-diaminohexanoic acid;2-oxopropanal Chemical class CC(=O)C=O.NCCCC[C@H](N)C(O)=O BOOXYSZJUWVNRE-JEDNCBNOSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/36—Control of physical parameters of the fluid carrier in high pressure liquid systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
- G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
- G01N30/724—Nebulising, aerosol formation or ionisation
- G01N30/7266—Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Dispersion Chemistry (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Dairy Products (AREA)
Abstract
The present invention discloses a method for detecting multiple advanced glycation end products in dairy products. Fig. l
Description
METHOD FOR DETECTING MULTIPLE ADVANCED GLYCATION END
PRODUCTS IN DAIRY PRODUCTS
The present invention relates to the technology field of food detection, specifically to a method for detecting multiple advanced glycation end products in dairy products.
Advanced glycation end products (AGEs) are a group of stable end-products generated by a series of reactions between free amino groups of proteins, amino acids, lipids or nucleic acids and the carbonyl group of reducing sugars through condensation, rearrangement, cleavage and oxidative modification. At present, more than 40 kinds of AGEs have been characterized and identified, wherein about 15 AGEs are found in foods, comprising free-type and peptide/protein-bound AGEs. Some AGEs such as carboxymethyl lysine (CML) are derived from lysine, while some AGEs are produced by modification of arginine, or by cross-linking these two amino acids at the same time.
Milk and dairy products with high nutritional value and unique flavor have become one of the main sources of nutrition in people's daily life. Milk products are rich in components such as lactose, whey protein, and caseins, which are prone to Maillard reaction to form various AGEs during food processing, storage and transportation.
Evidence keeps showing that the intake of food-borne AGEs has adverse effects on the human health and is closely related to many chronic diseases such as diabetes and chronic kidney disease. Due to the complexity and intractability of food substrates, as well as the wide variety of AGEs and complex structures, there has been a lack of universal, accurate and efficient methods for the detection of AGEs in food. At present, the detection methods of AGEs in food mainly comprise enzyme-linked immunosorbent assay, gas chromatography-mass spectrometry, high performance liquid chromatography, liquid chromatography tandem mass spectrometry and so on. Among them, the enzyme-linked immunoassay has limited application due to the unsatisfied accuracy and antibody specificity, while the gas chromatography-mass spectrometry method needs to derivatize the target, thereof the method is relatively cumbersome, and the recovery rate of the target is not high. Although liquid chromatography has a relatively high instrument popularity and simple operation, its detection sensitivity is not satisfied.
When detecting AGEs, using a liquid chromatography coupled with tandem mass spectrometer would greatly improve the sensitivity, selectivity and analysis speed of the method. However, the liquid chromatography-tandem mass spectrometry (LC-MS/MS) in the related field can only detect one to three AGEs products, and the efficiency is low, where it is difficult to objectively reflect the content and distribution of different AGEs in the food. In addition, the mass spectrometry technique is susceptible to errors caused by the matrix effect of samples, therefore it is necessary to fully consider the matrix effect when detecting samples with different matrices to improve the accuracy of the results.
Aiming at the above problems, the present invention provides a method for detecting multiple advanced glycation end products in dairy products. The method can detect 11
AGEs in dairy products at one time, comprising carboxymethyl lysine (CML), carboxyethyl lysine (CEL), pyrraline, pentosidine, methylacetaldehyde-hydroxyimidazolone isomer (MG-H1/MG-H2/MG-H3), argpyrimidine, glyoxal-hydroimidazolone (G-HI), glyoxal-lysine dimer (GOLD) and methylglyoxal-lysine dimer (MOLD), in order to achieve a comprehensive and accurate analysis of the content of AGEs in food.
In order to achieve the above objective, the embodiment of the present invention, on the one hand, provides a method for detecting multiple advanced glycation end products in dairy products, including the following steps: (1) adding the isotope internal standards into the dairy products after centrifugal degreasing, then adding borate buffer solution and sodium borohydride solution into the dairy products to obtain a mixed solution; (2) carrying out acid hydrolysis on the mixture, concentrating the mixture by vacuum centrifugation to near dryness, redissolving it with water, filtering to remove impurities thereof to obtain treated dairy products; (3) adding AGEs standards into the treated dairy products to make various AGEs standard solution, multiplying integral chromatographic area ratio of the isotope internal standard corresponding to each standard by the concentration of the corresponding isotope internal standard as a function of concentration of each standard to draw a standard curve;
(4) carrying out UPLC-MS/MS detection on the treated dairy products, obtaining the area of AGEs peak in the dairy products, and the concentration of each AGEs is calculated by substituting it into the standard curve.
According to the method of detecting multiple advanced glycation end products in dairy products in an embodiment of the present invention, the method calculates the correction factor by the isotope internal standard and the peak height/area of the corresponding standard, then uses the correction factor to correct the error caused by the pre-treatment of the sample. Pre-treatment steps thereof are simple, easy to operate, less impurity, and the standard curve is based on milk matrix, therefore greatly reduces the interference of matrix effect on the detection. The method can detect 11 AGEs of CML, CEL, pyrraline, pentosidine, MG-H1/3, MG-H2, argpyrimidine, G-H1, GOLD and MOLD at one time, and 11 AGEs have ideal separation effect, therefore achieve comprehensive and accurate analysis of the content of each AGE in the sample.
In addition, the method of detecting multiple advanced glycation end products in dairy products provided by the previously described embodiment of the present invention also includes the following additional technical characteristics:
Optionally, in step (1), the isotope internal standards include CML-d4, CEL-d4,
GOLD-15N2, MG-H1-d3 and G-H1-13C2.
Optionally, in step (1), 10 mL - 15 mL of 0.2 mol/L pH 9.2 borate buffer and 5 mL - 8 mL of 1 mol/L sodium borohydride solution prepared by 0.1 mol/L sodium hydroxide solution are added into each milliliter of dairy products, incubating for 2 to 4 h at room temperature to obtain a mixed solution.
Optionally, in step (2), the acid hydrolysis conditions are: adding 20 mL - 25 mL of 6 mol/L HCI into each milliliter of dairy products, and acid hydrolysis at 110 °C for 24 to 25 h.
Optionally, in step (1), the concentration of the isotope internal standard is 100 ng/mL ~200 ng/mL
Optionally, in step (1), the centrifugal degreasing conditions are: rotating speed is 4500-6000 g, temperature is 0-5 °C, time is 10-15 min.
Optionally, in step (2), the vacuum centrifugal concentration conditions are: vacuum degree is 0-1 mbar, rotation speed is 200-300 g, temperature is not higher than -20 °C.
Optionally, in step (3), the standard curve of CML is Y=0.01143X+0.000163, the standard curve of CEL is Y=0.02832X-0.01327, the standard curve of pyrraline is
Y=0.13448X-0.02140, and the standard curve of pentosidine is Y=0.00876 X+0.01663, the standard curve of MG-H1/3 is Y=0.00878X-0.00238, the standard curve of MG-H2 is
Y=0.00519X-0.00110, the standard curve of argpyrimidine is Y=0.05723X+0.05402, the standard curve of G-H1 is Y=0.00913X-0.00137, the standard curve of GOLD is
Y=0.01109X-0.00384, and the standard curve of MOLD is Y=0.04551X-0.0044.
Optionally, in step (4), the UPLC conditions are: column: Waters ACQUITY HSS T3 100 mmx2.1 mm 18 um; mobile phase A: aqueous solution containing 0.1% v/v formic acid; mobile phase B: acetonitrile; column temperature: 30 °C; flow rate: 0.25 mL/min; sample introduction volume: 5 pL; The sample is eluted by gradient elution, and the gradient is set to 98% A: 2% B, 95% A: 5% B, 90% A: 10% B, 92%A: 8%B, 98%A: 2%B. Therefore, by optimizing the liquid phase conditions such as the chromatographic column, mobile phase, and elution gradient, the detection time is shortened, the detection of 11 AGEs can be completed within 10 minutes, which greatly improves the detection efficiency.
Optionally, in step (4), the triple quadrupole mass spectrometry conditions are: ion source: electro-ion spray; scanning mode: positive ion mode; detection mode: MRM; desolventizing gas temperature: 600 °C; ion source temperature: 120 °C; desolventizing gas flow rate: 1000 L/h; gas flow rate of sampling cone: 200 L/h; collision gas flow rate: 0.20 mL/min; capillary voltage: 600 V; fragmentation voltage: 40 V.
The additional characteristics and advantages of the present invention will be partly described below, and some will become apparent from the following description or be known through implementation of the present invention.
FIG. I illustrates the schematic diagram of the chemical formula of 11 AGEs quantifiable according to an embodiment of the present invention;
FIG. 2 illustrates the ion chromatogram of CML quantified in ultra-high-temperature sterilized milk according to an embodiment of the present invention;
FIG. 3 illustrates the ion chromatogram of CEL quantified in ultra-high-temperature sterilized milk according to an embodiment of the present invent;
FIG. 4 illustrates the 10n chromatogram of MG-H1/3 quantified in ultra-high-temperature sterilized milk according to an embodiment of the present invention;
FIG. 5 illustrates the ion chromatogram of MG-H2 quantified in ultra-high-temperature sterilized milk according to an embodiment of the present invent;
FIG. 6 illustrates the ion chromatogram of GH-1 quantified in ultra-high-temperature 5 sterilized milk according to an embodiment of the present invent;
FIG. 7 illustrates the ion chromatogram of GOLD quantified in ultra-high-temperature sterilized milk according to an embodiment of the present invent;
FIG. 8 illustrates standard curve of CML in milk matrix according to an embodiment of the present invent;
FIG. 9 illustrates standard curve of CEL in milk matrix according to an embodiment of the present invent;
FIG. 10 illustrates standard curve of MG-H1/3 in milk matrix according to an embodiment of the present invent;
FIG. 11 illustrates standard curve of MG-H2 in milk matrix according to an embodiment of the present invent;
FIG. 12 illustrates standard curve of GH-1 in milk matrix according to an embodiment of the present invent; and
FIG. 13 illustrates standard curve of GOLD in milk matrix according to an embodiment of the present invent.
The following describes the technical solutions of the present invention through specific embodiments. It should be understood that, one or more steps mentioned in the present invention do not exclude other steps prior to or behind the sequenced steps or other steps inserted among those clearly mentioned steps. It should also be understood that, those embodiments are used to merely describe the present invention, not to limit the scope of the present invention. Moreover, unless otherwise specified, the serial numbers of steps are only convenient tools for distinguishing the steps instead of limiting the sequence of the steps or limiting the implementable scope of the present invention. Change or adjustment of the relative relationship of the serial numbers should also be deemed to fall within the implementable scope of the present invention if there is no substantial change to the technical contents.
To facilitate a better understanding of the previously described technical solution, exemplary embodiments of the present invention will be described in further detail.
Although exemplary embodiments of the present invention are illustrated, it should be understood that the present invention can be implemented in various forms and should not be limited by embodiments described herein. On the contrary, those embodiments are provided to help more thoroughly understand the present invention and entirely pass on the scope of the present invention to those skilled in the art.
The instruments and reagents used in the present invention were:
Agilent 1290 ultra performance liquid chromatograph, Agilent Technologies, USA;
Agilent 6470 Triple quadrupole mass spectrometer, Agilent Technologies, USA;
AUW220D electronic balance, Shimadzu Corporation, Japan;
Allegra X-30R multifunctional tabletop high-speed centrifuge, Beckman Coulter,
Germany;
ED56 natural convection oven, Binder GmbH, Germany;
Milli-Q Advantage A 10 ultra-pure water meter, Bedford, USA;
ZLS-2 vacuum centrifugal concentrator, Hunan Hexi Instrument Equipment Co., Ltd;
CML, CEL standard products, Cayman Chemical, USA;
Pyrraline standard, pentosidine standard, MG-H1/3 standard, MG-H2 standard, argpyrimidine standard, G-H1 standard, GOLD standard, MOLD standard, CML-d4 standard, CEL-d4 standard, GOLD-15N2 standard, MG-H1-d3 standard, G-H1-13C2 standard, Iris Biotech GmbH, Germany;
Sodium tetraborate, sodium borohydride, sodium hydroxide, hydrochloric acid, formic acid, acetonitrile, Shanghai Aladdin Biochemical Technology Co., Ltd;
Storage bottle, Agilent Technologies, USA; 0.22 um filter membrane, 2.5 mL syringe, threaded tube, sample bottle, centrifuge tube,
Shenggong Bioengineering (Shanghai) Co., Ltd;
The following describes the present invention by reference to specific embodiments. It should be noted that those embodiments are merely descriptive and do not limit the present invention in any way.
Extraction of AGEs
Taking 1 mL of ultra-high-temperature sterilized milk into a 1.5 mL centrifuge tube, degreasing at 4500g for 15 minutes, taking 100 uL sample from the bottom of the centrifuge tube into a threaded tube, adding 10 pL of 10 pg/mL CML-d4, 10 pL of 10 ng/mL CEL-d4, 10 uL of 10 pg/mL GOLD-15N2, 10 pL of 10 pg/mL MG-H1-d3, and 10 uL of 10 pg/mL G-H1-13C2 isotope internal standards to correct for errors, adding 1 mL of 0.2 mol/L pH 9.2 borate buffer and 0.5 mL of sodium borohydride solution prepared by 1 mol/L sodium hydroxide solution, incubating for 2 h at room temperature to obtain a mixed solution;
Adding 1.5 mL of 6 mol/L HCI to the mixture, acid hydrolyzing at 110 °C for 24 h to dissociate the bound AGEs, therefore turn them into free AGEs, thereafter, concentrating the mixture by vacuum centrifugation to near dryness at a vacuum of 0.1 mbar, rotating speed 200 g, -20 °C, adding 5 mL of ultra-pure water to redissolve the residue, then obtaining the redissolution;
Passing the redissolution through a 0.22 um filter membrane, obtaining the filtrate;
The use of ion source as electrospray mass spectrometry to analyze target analytes in food samples may cause ionization inhibition or ionization enhancement due to the chromatographic elution of matrix components, thereby affecting the quantitative results.
Therefore, the matrix effect level of the established method was evaluated by measuring the slope change (%) of the matrix standard curve and the solvent standard curve, the matrix effect level was calculated by the following formula:
Matrix effect (%) = (Slope of the matrix standard curve - slope of the solvent standard curve) / slope of the matrix standard curve
A negative level (<10%) of the matrix effect indicated that the matrix may suppress the mass spectrometry signal, while a positive level (>10%) indicated that the matrix may enhance the mass spectrometry signal. When the matrix effect level remained in the range of -10-10%, it could be considered that there is no matrix effect during the analysis of the target analyte.
Making the standard curve:
Using 5 pg/mL CML, 5 pg/mL CEL, 5 pg/mL pyrraline, 5 pg/mL pentosidine, 5 pg/mL
MG-H1, 5 pg/mL MG-H2, 5 pg/mL MG-H3, 5 pg /mL argpyrimidine, 5 pg/mL G-HI, 5 ug/mL GOLD, 5 pg/mL MOLD to prepare a mixed standard solution with a final concentration of 1 pg/mL for each standard, and then using 10 pg/mL CML- d4, 10 pg/mL
CEL-d4, 10 pg/mL GOLD-15N2, 10 pg/mL MG-H1-d3, 10 pg/mL G-H1-13C2 to prepare a mixed internal standard solution with a final concentration of 1 ug/ mL for each internal standard, and finally prepared 1 mL mixed standard solution containing 0.1 pg/mL mixed internal standard solution of 5 ng/mL, 25 ng/mL, 50 ng/mL, 100 ng/mL, 250 ng/mL and 500 ng /mL, the matrix was the filtrate obtained in the above steps, and the standard solution preparation conditions were shown in Table 1;
Table 1 Standard solution preparation conditions ngmL ng/mL ng/mL ng/mL ng/mL ng/mL
Mixed standard solution ~~ 5uL ~~ 25ul 30pL 100uL 2504 S00 ul
Mixed internal standard lution 100 ul 100pL 100pL 100uL 100uL 100 pL
Matrix [06 uL 100 uL 100 uL 100 uL 100 pL 100 pL
Ultra-pure water 795uL 775uL 750uL 700uL 550uL 300 pL
The preparation condition of the standard solution of the solvent standard curve was to replace the same amount of the matrix added in Table 1 with ultra-pure water;
Multiplying the integral chromatographic peak area ratio of the isotope internal standard corresponding to each standard by the concentration (Y) of each corresponding isotope internal standard as a function of the standard concentration (X) to draw a standard curve to obtain the equation. As shown in FIG. 8-FIG. 13. The standard curve of CML was
Y=0.01143X+0.000163, the standard curve of CEL was Y=0.02832X-0.01327, the standard curve of pyrraline was Y=0.13448X-0.02140, the standard curve of pentosidine was Y=0.00876X+0.01663, the standard curve of MG-H1/3 was Y=0.00878X-0.00238, the standard curve of MG-H2 was Y=0.00519X-0.00110, the standard curve of argpyrimidine was Y=0.05723X+0.05402, the standard curve of G-Hl was Y=0.00913
X-0.00137, the standard curve of GOLD was Y=0.01109X-0.00384, and the standard curve of MOLD was Y=0.04551X-0.0044.
The matrix effect level result was calculated according to the matrix effect formula. The matrix effect of CML was -3.2%, the matrix effect of CEL was -2.6%, the matrix effect of pyrraline was -1.7%, the matrix effect of pentosidine was -5.4%, the matrix effect of
MG-H1/3 was -4.8%, the matrix effect of MG-H2 was -2.9%, the matrix effect of argpyrimidine was -3.5%, the matrix effect of G-H1 was -2.8%, the matrix effect of
GOLD was -1.7%, and the matrix effect of MOLD was -4.1%.
UPLC-MS/MS detection
The conditions of UPLC: column: Waters ACQUITY HSS T3 (100 mmx2.1 mm 18 um); mobile phase A: an aqueous solution containing 0.1% (v/v) formic acid; mobile phase B: acetonitrile; column temperature: 30°C; flow rate: 0.25 mL/min; sample instruction volume: 5 pL; the gradient elution is shown in Table 2;
Table 2 Gradient elution program
Time (min) 0 2 6 9 10
A 98% 95% 90% 92% 98%
B 2% 5% 10% 8% 2%
Using the above gradient elution, CML, CEL, pyrraline, pentosidine, MG-H1/3, MG-H2, argpyrimidine, G-HI, GOLD, MOLD had extremely short detection time and excellent separation effect, the retention times were 4.32 min, 4.92 min, 5.67 min, 8.64 min, 6.22 min, 7.29 min, 5.61 min, 8.12 min, 8.33 min, which was beneficial to improve the accuracy and precision of analyzing and quantifying; and under this elution gradient , the analyte retention value was appropriate and the peak shape was good.
The conditions of triple quadrupole mass spectrometry: ion source: electro-ion spray; scanning mode: positive ion mode; detection mode: MRM; desolventizing gas temperature: 600 °C; ion source temperature: 120 °C; desolventizing gas flow rate: 1000 L/h; gas flow rate of sampling cone: 200 L/h; collision gas flow rate: 0.20 mL/min; capillary voltage: 600 V;
fragmentation voltage: 40 V,
MRM mass spectrometer parameters were shown in Table 3:
Table 3 MRM mass spectrum parameters
Analyte Prerequisite ion Quantitative ion (m/z) Collision energy (eV) (m/z)
CML 2050 116 84 27
CEL 219.0 130* 17 84 26
Pyrraline 255.1 130% 18 174.9 17
Pentosidine 380.2 251.0% 32 317.1 35
MG-H1/3 229.1 114.1% 20 210.8 12
MG-H2 229.1 116.0% 19 211.0 16
Argpyrimidine 255.1 139.7* 22 116.0 21
G-H1 215.2 116.1% 19 152.2 20
GOLD 328.2 130.1* 31 283.1 30
MOLD 342.3 297.1% 30 252.2 40
CML-d4 209.0 134.0% 16
CEL-d4 223.0 134.0% 18
GOLD-15N2 330.0 130.8* 28
MG-H1-d3 231.0 116.0% 21
G-H1-13C2 217.1 153.9% 18
TT
The quantitative ion pair in the table was marked with "*".
Carrying out UPLC-MS/MS detection on the treated samples, the detection mode was
MRM, obtaining the area of AGEs peak in the sample, calculating the concentration of
AGEs in the sample.
The results were shown in FIG. 2 to FIG. 7, the ion chromatographic peaks of CML, CEL,
MG-H1/3, MG-H2, G-H1, GOLD in ultra-high-temperature sterilized milk, according to the standard curve, the concentration of CML was 0.555 pg/mL, the concentration of CEL was 0.240 pg/mL, the concentration of MG-H1/3 was 19.917 ng/mL, the concentration of
MG-H2 was154.239 pg/mL, the concentration of G-HI was 8.708 pg/mL, the concentration of GOLD was 1.346 pg/mL. The concentrations of the other AGEs were all lower than the quantitative limitation of the method.
In summary, according to the embodiment of the present invention, the content of each
AGEs in the food can be comprehensively and accurately analyzed.
In the description of the present invention, reference terms including one embodiment, some embodiments, example, specific example or some examples refer to that specific characteristics, structures, materials or features which are described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In the present description, the schematic expression of the above terms should not be construed as always aiming at identical embodiments or examples. Besides, the described specific characteristics, structures, materials or features may be combined in an appropriate way in any one of or more embodiments. In addition, those skilled in the art can blend and combine different embodiments or examples described in the present invention.
Although the embodiments of the present invention have been illustrated and described above, it can be understood that the previously described embodiments are exemplary, and cannot be construed as limiting the present invention. Those ordinarily skilled in the art can change, modify, replace and transform the previously described embodiments within the scope of the present invention.
Claims (10)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111058154.2A CN113702546A (en) | 2021-09-09 | 2021-09-09 | Method for detecting multiple advanced glycosylation end products in dairy product |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2029775B1 true NL2029775B1 (en) | 2023-01-03 |
Family
ID=78659768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2029775A NL2029775B1 (en) | 2021-09-09 | 2021-11-16 | Method for detecting multiple advanced glycation end products in dairy products |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN113702546A (en) |
NL (1) | NL2029775B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113808674B (en) * | 2021-08-11 | 2023-09-08 | 天津科技大学 | Calculation method and application of Maillard reaction byproduct content of dairy product added with tea polyphenol |
CN114674954A (en) * | 2022-03-25 | 2022-06-28 | 浙江工商大学 | Method for detecting Maillard reaction products in different stages in processed food |
CN115015429A (en) * | 2022-06-20 | 2022-09-06 | 哈尔滨商业大学 | Method for synchronously detecting middle-and-late-stage glycosylation end products of polygonatum sibiricum |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106124641B (en) * | 2016-05-13 | 2019-01-29 | 中华全国供销合作总社杭州茶叶研究所 | A kind of synchronous method for detecting carboxymethyl-lysine and lysopine in green tea |
CN110243952A (en) * | 2019-03-14 | 2019-09-17 | 南京市产品质量监督检验院 | A method of using each component content of AGEs in HPLC-MS/MS standard measure measurement milk powder |
CN110988193A (en) * | 2019-12-24 | 2020-04-10 | 中国海洋大学 | Method for detecting advanced glycosylation end products in aquatic products |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104634897B (en) * | 2015-02-14 | 2016-08-17 | 中国烟草总公司郑州烟草研究院 | A kind of method detecting cigarette mainstream flue gas middle and advanced stage advanced glycation end products |
JP6667229B2 (en) * | 2015-08-31 | 2020-03-18 | 学校法人東海大学 | Sample preparation method for terminal glycation product analysis and terminal glycation product analysis method |
CN111122733A (en) * | 2019-12-27 | 2020-05-08 | 江南大学 | Method for synchronously measuring three late glycosylation products |
-
2021
- 2021-09-09 CN CN202111058154.2A patent/CN113702546A/en active Pending
- 2021-11-16 NL NL2029775A patent/NL2029775B1/en active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106124641B (en) * | 2016-05-13 | 2019-01-29 | 中华全国供销合作总社杭州茶叶研究所 | A kind of synchronous method for detecting carboxymethyl-lysine and lysopine in green tea |
CN110243952A (en) * | 2019-03-14 | 2019-09-17 | 南京市产品质量监督检验院 | A method of using each component content of AGEs in HPLC-MS/MS standard measure measurement milk powder |
CN110988193A (en) * | 2019-12-24 | 2020-04-10 | 中国海洋大学 | Method for detecting advanced glycosylation end products in aquatic products |
Non-Patent Citations (2)
Title |
---|
AKILLIOGLU HALISE GÜL ET AL: "Quantification of advanced glycation end products and amino acid cross-links in foods by high-resolution mass spectrometry: Applicability of acid hydrolysis", FOOD CHEMISTRY, ELSEVIER LTD, NL, vol. 366, 15 July 2021 (2021-07-15), XP086768254, ISSN: 0308-8146, [retrieved on 20210715], DOI: 10.1016/J.FOODCHEM.2021.130601 * |
LI CHUNHAI ET AL: "Robust Detection of Advanced Glycation Endproducts in Milk Powder Using Ultrahigh Performance Liquid Chromatography Tandem Mass Spectrometry (UHPLC-MS/MS)", FOOD ANALYTICAL METHODS, SPRINGER NEW YORK LLC, US, vol. 14, no. 7, 27 February 2021 (2021-02-27), pages 1472 - 1481, XP037490714, ISSN: 1936-9751, [retrieved on 20210227], DOI: 10.1007/S12161-021-01986-6 * |
Also Published As
Publication number | Publication date |
---|---|
CN113702546A (en) | 2021-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL2029775B1 (en) | Method for detecting multiple advanced glycation end products in dairy products | |
CN110542735A (en) | method for high-throughput determination of multiple fat-soluble vitamins by ultra-high performance liquid mass spectrometry | |
CN109085278B (en) | Kit for simultaneously detecting multiple amino acids by liquid chromatography-tandem mass spectrometry and application thereof | |
CN112730723B (en) | Method for detecting 22 free amino acids in plasma by ultra-high performance liquid chromatography-tandem mass spectrometry | |
CN113480599A (en) | Characteristic polypeptide for identifying deer antler glue of sika deer or red deer and application thereof | |
CN110988193B (en) | Method for detecting advanced glycosylation end products in aquatic products | |
CN107843672B (en) | Method for detecting amino acid in serum by high performance liquid chromatography-tandem mass spectrometry | |
CN113720946A (en) | Method and kit for detecting multiple steroid hormones in blood | |
CN112730706A (en) | Method for detecting biological small molecule marker by liquid chromatography-tandem mass spectrometry | |
CN110133169A (en) | A kind of method and application using frusemide in LC-MS detection human plasma | |
CN103792315B (en) | Quantifying method for human albumin inorganic mass spectrum coupling technique | |
CN111474278B (en) | Method and kit for detecting metabolites of macrolide compounds | |
CN109342627B (en) | Method for detecting amino acid in cell culture | |
CN114624362A (en) | Kit for detecting advanced glycosylation end products in serum and application thereof | |
CN113866305A (en) | Method for rapidly and accurately analyzing theanine in fresh tea leaves based on liquid chromatography-mass spectrometry technology | |
CN110007023B (en) | High-resolution mass spectrum screening method for sulfonamides in fish body and analysis method for interaction of sulfonamides and protein macromolecules | |
CN114137097A (en) | Method for detecting melatonin in milk by liquid chromatography-tandem mass spectrometry and performance evaluation thereof | |
CN112485340A (en) | Method for detecting 1, 5-sorbitan in plasma by ultra-high performance liquid chromatography tandem mass spectrometry | |
CN109655531B (en) | Method for simultaneously analyzing short-chain, medium-chain and long-chain acyl coenzyme A | |
CN111812243B (en) | Analysis method for reducing matrix effect in whole blood cyclosporine determination | |
CN111413439A (en) | Method for determining metformin in blood plasma by rapid hydrophilic interaction chromatography-tandem mass spectrometry | |
CN113203805B (en) | Liquid chromatography tandem mass spectrometry method for simultaneously measuring glucose, fructose and 1, 5-deoxyglucitol in blood | |
CN118501300B (en) | Method for detecting total content of proline or hydroxyproline dipeptide in collagen peptide | |
CN110426470B (en) | Method for measuring biotin content in eggs | |
CN112213420B (en) | Method for rapidly determining multicomponent mycotoxins in beans and bean products |